The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kaibysheva V.O.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
City Clinical Hospital №31, Moscow, Russia

Fedorov E.D.

Kafedra gospital'noĭ khirurgii #2 i nauchno-issledovatel'skaia laboratoriia khirurgicheskoĭ gastronterologii i ndoskopii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova

Mikhaleva L.M.

Research Institute of Human Morphology, Moscow, Russia

Erdes S.I.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Lokhmatov M.M.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Tertychny A.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Ivanova E.V.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Nikonov E.L.

FGBU "Poliklinika #1" Upravleniia delami Prezidenta RF

Antishin A.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Shapoval’yants S.G.

Department of Hospital Surgery №2 with the research laboratory of surgical gastroenterology and endoscopy, N.I. Pirogov Russian National Research Medical University, Moscow

The main statements of the European society of eosinophilic oesophagitis guidelines

Authors:

Kaibysheva V.O., Fedorov E.D., Mikhaleva L.M., Erdes S.I., Lokhmatov M.M., Tertychny A.S., Ivanova E.V., Nikonov E.L., Antishin A.S., Shapoval’yants S.G.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2018;7(3): 65‑90

DOI: 10.17116/dokgastro2018703165

Views: 1147

Downloaded: 75

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kaibysheva VO, Fedorov ED, Mikhaleva LM, et al. . The main statements of the European society of eosinophilic oesophagitis guidelines. Russian Journal of Evidence-Based Gastroenterology. 2018;7(3):65‑90. (In Russ.)
https://doi.org/10.17116/dokgastro2018703165

Подписка 2025 (Russian Journal of Evidence-Based Gastroenterology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Prognostic value of outpatient endo­scopy for the diagnosis of eosi­nophilic esophagitis in children. Russian Journal of Evidence-Based Gastroenterology. 2023;(4):5-10
Pathomorphological criteria and features of immune response in eosi­nophilic esophagitis and reflux esophagitis. Russian Journal of Archive of Pathology. 2024;(1):5-12

Aim. To present and discuss the main statements of the European society of eosinophilic oesophagitis guidelines (2017). Material and methods. A considerable progress has been achieved in research of eosinophilic oesophagitis (EoE) for the last years: large-scale controlled randomized trials have been carried out, several systematic reviews were published. These data demonstrated the necessity to reconsider current guidelines taking into consideration fundamental principles of evidence-based medicine. Expert group meeting for development of new guidelines for management of eosinophilic oesophagitis took place on October 16, 2016 within the 24th United european gastroenterology week. All items of the guidelines were evaluated in terms of evidence level (high, intermediate, low, and very low) and grade of recommendations as strong or weak (only for recommendations concerning diagnostics and treatment of eosinophilic oesophagitis). The result is proposal of new recommendations under the title of «Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in the children and adults». Conclusion. New evidence-based «Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in the children and adults» allow to optimize diagnosis of the disease, improve the outcomes and reduce risk of complications.

Keywords:

eosinophilic esophagitis
oesophageal eosinophilia
proton pump inhibitors

Authors:

Kaibysheva V.O.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
City Clinical Hospital №31, Moscow, Russia

Fedorov E.D.

Kafedra gospital'noĭ khirurgii #2 i nauchno-issledovatel'skaia laboratoriia khirurgicheskoĭ gastronterologii i ndoskopii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova

Mikhaleva L.M.

Research Institute of Human Morphology, Moscow, Russia

Erdes S.I.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Lokhmatov M.M.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Tertychny A.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Ivanova E.V.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Nikonov E.L.

FGBU "Poliklinika #1" Upravleniia delami Prezidenta RF

Antishin A.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Shapoval’yants S.G.

Department of Hospital Surgery №2 with the research laboratory of surgical gastroenterology and endoscopy, N.I. Pirogov Russian National Research Medical University, Moscow

List of references:

  1. Landers R, et al. Eosinophilic esophagitis in patients with vigorous achalasia. Gastroenterology. 1978;74:1298-1301.
  2. Attwood SE, Smyrk TC and Demeester TRJJ. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109-116.
  3. Straumann A, Spichtin HP, Bernoulli R, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr. 1994;124:1419-1429.
  4. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-1363.
  5. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20. https://doi.org/10.1016/j.jaci.2011.02.040
  6. Papadopoulou A, Koletzko S, Heuschkel R, et al. Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr. 2014;58:107-118.
  7. Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679-692.
  8. Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, Santander C, Schoepfer AM, Storr MA, Terreehorst I, Straumann A, Attwood SE. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3):335-358. https://doi.org/10.1177/2050640616689525
  9. Molina-Infante J, Bredenoord AJ, Cheng E, et al. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2016;65:524-531. https://doi.org/10.1136/gutjnl-2015-310991
  10. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110-117. https://doi.org/10.1016/j.cgh.2010.09.019
  11. Francis DL, Foxx-Orenstein A, Arora AS, et al. Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2012;35:300-307. https://doi.org/10.1111/j.1365-2036.2011.04922.x
  12. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, et al. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013;38:1312-1319. https://doi.org/10.1111/apt.12513
  13. Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Aliment Pharmacol Ther. 2013;108:1854-1860. https://doi.org/10.1038/ajg.2013.363
  14. Moawad FJ, Schoepfer AM, Safroneeva E, et al. Eosinophilic oesophagitis and proton pump inhibitor- responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharmacol Ther. 2014;39:603-608.
  15. Molina-Infante J, Rivas MD, Hernandez-Alonso M, et al. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther. 2014;40:955-965.
  16. Dellon ES, Speck O, Woodward K, et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12:2015-2022.
  17. Moawad FJ, Wells JM, Johnson RL, et al. Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesopha- geal eosinophilia and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2015;42:231-238. https://doi.org/10.1111/apt.13258
  18. Van Rhijn BD, Weijenborg PW, Verheij J, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1815-1823. https://doi.org/10.1016/j.cgh.2014.02.037
  19. Wen T, Dellon ES, Moawad FJ, et al. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor- reversible allergic inflammation. J Allergy Clin Immunol. 2015;1:135:187—197.
  20. Zhang X, Cheng E, Huo X, Yu C, Zhang Q, Pham TH, Wang DH, Spechler SJ, Souza RF. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One. 2012;7(11):50037.
  21. Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824-832.
  22. Ishimura N, Ishihara S, Kinoshita Y. Sustained acid suppression by potassium- competitive acid blocker (P-CAB) may be an attractive treatment candidate for patients with eosinophilic esophagitis. Am J Gastroenterol. 2016;111:1203-1204.
  23. Krarup AL, Villadsen GE, Mejlgaard E, et al. Acid hypersensitivity in patients with eosinophilic oesophagitis. Scand J Gastroenterol. 2010;45:273-281. https://doi.org/10.3109/00365520903469931
  24. Sayej WN, Patel R, Baker RD, et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009;49:393-399.
  25. Pentiuk S, Putnam PE, Collins MH, et al. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009;48:152-160.
  26. Molina-Infante J, van Rhijn BD. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol. 2015;29:749-758.
  27. Levine J, Lai J, Edelman M, et al. Conservative long-term treatment of children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2012;108:363-366.
  28. Arias A, Lucendo AJ. Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol. 2013;25:208-212.
  29. Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128:1349-1350.
  30. Straumann A, Simon H-U. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115:418-419.
  31. Giriens B, Yan P, Safroneeva E, et al. Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993—2013: a population-based study. Allergy. 2015;70:1633-1639.
  32. Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055-1061.
  33. Dellon ES, Jensen ET, Martin CF, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12:589-596.
  34. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. New England J Med. 2004;351;940-941.
  35. Syed AN, Andrews CN, Shaffer E, et al. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study. Aliment Pharmacol Ther. 2012;36:950-958. https://doi.org/10.1111/apt.12053
  36. Stewart MJ, Shaffer E, Urbanski SJ, et al. The association between celiac disease and eosinophilic esophagitis in children and adults. BMC Gastroenterol. 2013;13:96.
  37. Maradey-Romero C, Prakash R, Lewis S, et al. The 2011—2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther. 2015;41:1016-1022.
  38. Prakash R, Maradey C, Fass R. Eosinophilic esophagitis is much less common than previously thought: a large nationwide database study. Am J Gastroenterol. 2013;108:33.
  39. Dellon ES, Erichsen R, Baron JA, et al. The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther. 2015;41:662-670.
  40. Soon IS, Butzner JD, Kaplan GG, et al, Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2013;57:72-80.
  41. Arias A, Perez-Martinez I, Tenias JM, et al. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43:3-15.
  42. Veerappan GR, Perry JL, Duncan TJ, et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009;7:420-426.
  43. Foroutan M, Norouzi A, Molaei M, et al. Eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease. Dig Dis Sci. 2010;55:28-31.
  44. Garcia-Compean D, Gonzalez Gonzalez JA, Marrufo Garcia CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis. 2011;43:204-208.
  45. Salem SB, Kushner Y, Marcus V, et al. The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy. Can J Gastroenterol. 2009;23:99-104.
  46. Poh CH, Gasiorowska A, Navarro-Rodriguez T, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71:28-34.
  47. Sá CC, Kishi HS, Silva-Werneck AL, et al. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics (Sao Paulo). Brazil; 2011;66:557-561.
  48. Achem SR, Almansa C, Krishna M, et al. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011;33:1194-1201.
  49. Ricker J, McNear S, Cassidy T, et al. Routine screening for eosinophilic esophagitis in patients presenting with dysphagia. Therap Adv Gastroenterol. 2011;4:27-35.
  50. Savarino E, Tolone S, Caccaro R, et al. Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis. Dig Liver Dis. 2015;47:1033-1038.
  51. Sperry SLW, Crockett SD, Miller CB, et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74:985-991.
  52. Desai TK, Stecevic V, Chang C-H, et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795-801.
  53. Kerlin P, Jones D, Remedios M, et al. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol. 2007;41:356-361.
  54. Hurtado CW, Furuta GT, Kramer RE. Etiology of esophageal food impactions in children. J Pediatr Gastroenterol Nutr. 2011;52:43-46. https://doi.org/10.1097/MPG.0b013e3181e67072
  55. Thakkar K, Chen L, Tatevian N, et al. Diagnostic yield of oesophagogastroduodenoscopy in children with abdominal pain. Aliment Pharmacol Ther. 2009;30:662-669.
  56. Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134:1316-1321.
  57. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-1206.
  58. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48:30-36.
  59. Castro Jimenez A, Gomez Torrijos E, Garcia Rodriguez R, et al. Demographic, clinical and allergological characteristics of Eosinophilic Esophagitis in a Spanish central region. Allergol Immunopathol (Madr). 2014;42:407-414. https://doi.org/10.1016/j.aller.2013.04.004
  60. van Rhijn BD, Verheij J, Smout AJ, et al. Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil. 2013;25:47-52.
  61. Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134:1084-1092.
  62. Sherrill JD, Gao P-S, Stucke EM, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126:160-165.
  63. González-Cervera J; Arias Á; Redondo-González O; et al. The association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asth Immunol. 2017.
  64. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503-1512.
  65. Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828-833.
  66. Chehade M. IgE and non-IgE-mediated food allergy: Treatment in 2007. Curr Opin Allergy Clin Immunol. 2007;7:264-268.
  67. Simon D, Marti H, Heer P, et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol. 2005;115:1090-1092.
  68. Gonsalves N, Yang G-Y, Doerfler B, et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142:1451-1455.
  69. Lucendo AJ, Arias A, Gonzalez-Cervera J, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131:797-804. https://doi.org/10.1016/j.jaci.2012.12.664
  70. Ludvigsson JF, Aro P, Walker MM, et al. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol. 2013;48:808-814.
  71. Lucendo AJ, Arias A, Perez-Martinez I, et al. Adult patients with eosinophilic esophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac disease. Dig Dis Sci. 2011;56:1107-1111.
  72. Dobbins JW, Sheahan DG BJ. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology. 1977;72:1312-1316.
  73. Ko HM, Morotti RA, Yershov O, et al. Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy. Am J Gastroenterol. 2014;109:1277-1285.
  74. Ivashkin VT, Baranskaya EK, Kaibysheva VO, Ivanova EV, Fedorov ED. Eozinofil’nyi ezofagit: obzor literatury i opisanie sobstvennogo nablyudeniya. RZhGGK. 2012;1:71-81. (In Russ.)
  75. Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305-1313.
  76. Remedios M, Campbell C, Jones DM, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3-12.
  77. Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516-522.
  78. Kahn J, Bussmann C, Beglinger C, et al. Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis. Am J Med. 2015;128:196-199.
  79. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313-319.
  80. Shah A, Kagalwalla AF, Gonsalves N, et al. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol. 2009;104:716-721.
  81. Peery AF, Cao H, Dominik R, et al. Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011;9:475-480. https://doi.org/10.1016/j.cgh.2011.02.026
  82. Dellon ES, Speck O, Woodward K. The patchy nature of esophageal eosinophilia in eosinophilic esophagitis: Insights from pathology samples from a clinical trial. Gastroenterology. 2012;142(Suppl):S-1129.
  83. Saffari H, Peterson KA, Fang JC, et al. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: Implications for endoscopic biopsy. J Allergy Clin Immunol. 2012;130:798-800.
  84. Gupta SK, Fitzgerald JF, Chong SK, et al. Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children? Gastrointest Endosc. 1997;45:485-489.
  85. Lim JR, Gupta SK, Croffie JM, et al. White specks in the esophageal mucosa: an endoscopic manifestation of non-reflux eosinophilic esophagitis in children. Gastrointest Endosc. 2004;59:835-388.
  86. Straumann A, Spichtin H-P, Bucher KA, et al. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion. 2004;70:109-116.
  87. Kim HP, Vance RB, Shaheen NJ, et al. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a metaanalysis. Clin Gastroenterol Hepatol. 2012;10:988-996.
  88. Dellon ES, Aderoju A, Woosley JT, et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102:2300-2313.
  89. Peery AF, Shaheen NJ, Dellon ES. Practice patterns for the evaluation and treatment of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2010;32:1373-1382.
  90. Sperry SLW, Shaheen NJ, Dellon ES. Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE. Am J Gastroenterol. 2011;106:824-832.
  91. Steiner SJ, Gupta SK, Croffie JM, et al. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Am J Gastroenterol. 2004;99:801-805.
  92. Genevay M, Rubbia-Brandt L, Rougemont A-L. Do eosinophil numbers differentiate eosinophilic esophagitis from gastroesophageal reflux disease? Arch Pathol Lab Med. 2010;134:815-825.
  93. Fiocca R, Mastracci L, Engström C, et al. Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial. Am J Gastroenterol. 2010;105:1015-1023.
  94. Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:435-442.
  95. Parfitt JR, Gregor JC, Suskin NG, et al. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol an Off J United States Can Acad Pathol Inc. 2006;19:90-96.
  96. Dellon ES, Speck O, Woodward K, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28:383-390.
  97. Mueller S, Neureiter D, Aigner T, et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology. 2008;53:676-684.
  98. Protheroe C, Woodruff SA, de Petris G, et al. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2009;7:749-755.
  99. Aceves SS. Tissue remodeling in patients with eosinophilic esophagiÂtis: what lies beneath the surface? J Allergy Clin Immunol. 2011;128:1047-1049.
  100. Dellon ES, Chen X, Miller CR, et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:264-271.
  101. Saffari H, Hoffman LH, Peterson KA, et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014;133:1728-1734.
  102. Capocelli KE, Fernando SD, Menard-Katcher C, et al. Ultrastructural features of eosinophilic oesophagitis: impact of treatment on desmosomes. J Clin Pathol. 2015;68:51-56.
  103. Ravelli A, Villanacci V, Cadei M, et al. Dilated intercellular spaces in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2014;59:589-593. https://doi.org/10.1097/MPG.0000000000000491
  104. Simon D, Radonjic-Hosli S, Straumann A, et al. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation. Allergy. 2015;70:443-452.
  105. Collins MH, Martin LJ, Alexander ES, Boyd JT, Sheridan R, He H, Pentiuk S, Putnam PE, Abonia JP, Mukkada VA, Franciosi JP, Rothenberg ME. Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus. 2017 1;30(3):1-8. https://doi.org/10.1111/dote.12470
  106. Baxi S, Gupta SK, Swigonski N, et al. Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc. 2006;64:473-478.
  107. Konikoff MR, Blanchard C, Kirby C, et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1328-1336.
  108. Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526-1537.
  109. Filik L. Montelukast and maintenance of steroid-induced remission in eosinophilic esophagitis. Dig Dis Sci. 2012;57:258-259.
  110. Rodriguez-Sanchez J, Gomez-Torrijos E, de-la-Santa-Belda E, et al. Effectiveness of serological markers of eosinophil activity in monitoring eosinophilic esophagitis. Rev Esp Enferm Dig. 2013;105:462-467.
  111. Schlag C, Miehlke S, Heiseke A, et al. Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015;42:1122-1130. https://doi.org/10.1111/apt.13386
  112. Min SB, Nylund CM, Baker TP, Ally M, Reinhardt B, Chen YJ, Nazareno L, Moawad FJ. Longitudinal evaluation of noninvasive biomarkers for eosinophilic esophagitis. J Clin Gastroenterol. 2017;51(2):127-135.
  113. Rao GS, Mitchell L, Ohnuki JF, et al. Can eosinophil derived neurotoxin (EDN) act as a surrogate marker of disease activity in children with allergic eosinophilic esophagitis (AEE)? Gastrointest Endosc. 2004;59:P103.
  114. Leung J, Nguyen-Traxler A, Lee EM, et al. Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy Asthma Proc. 2012;33:519-524.
  115. Dellon ES, Rusin S, Gebhart JH, et al. Utility of a noninvasive serum biomarker panel for diagnosis and monitoring of eosinophilic esophagitis: a prospective study. Am J Gastroenterol. 2015;110:821-827. https://doi.org/10.1038/ajg.2015.57
  116. Furuta GT, Kagalwalla AF, Lee JJ, et al. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut. 2013;62:1395-1405.
  117. Katzka DA, Geno DM, Ravi A, et al. Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13:77-83.
  118. Schoepfer AM, Straumann A, Panczak R, et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014;147:1255-1266.
  119. Safroneeva E, Straumann A, Coslovsky M, et al. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology. 2016;150:581-590. https://doi.org/10.1053/j.gastro.2015
  120. Dellon ES, Irani A-M, Hill MR, et al. Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis. Aliment Pharmacol Ther. 2013;38:634-642. https://doi.org/10.1111/apt.12413
  121. Franciosi JP, Hommel KA, DeBrosse CW, et al. Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods. BMC Gastroenterol. 2011;11:126.
  122. Martin LJ, Franciosi JP, Collins MH, et al. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol. 2015;135:1519-1528.
  123. Taft TH, Kern E, Kwiatek MA, et al. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther. 2011;34:790-798.
  124. Franciosi JP, Hommel KA, Bendo CB, et al. PedsQL eosinophilic esophagitis module: Feasibility, reliability and validity. J Pediatr Gastroenterol Nutr. 2013;57:57-66.
  125. Kwiatek MA, Hirano I, Kahrilas PJ, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140:82-90.
  126. Nicodeme F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11:1101-1107.
  127. French comment on article: Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis. Endoscopy. 2016;48:873.
  128. Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489-495.
  129. Dellon ES, Cotton CC, Gebhart JH, et al. Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to rreatment. Clin Gastroenterol Hepatol. 2016;14:31-39.
  130. van Rhijn BD, Warners MJ, Curvers WL, et al. Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability. Endoscopy. 2014;46:1049-1055. https://doi.org/10.1055/s-0034-1377781
  131. van Rhijn BD, Verheij J, Smout AJ, et al. The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2016;28:1714-1722. https://doi.org/10.1111/nmo.12872
  132. Straumann A, Spichtin H-P, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660-1669.
  133. Assa’ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007;119:731-738.
  134. Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230-1232.
  135. Lipka S, Kumar A, Richter JE. Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol. 2016;50:134-140.
  136. Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109-116.
  137. Lieberman JA, Morotti RA, Konstantinou GN, et al. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy. 2012;67:1299-1307. https://doi.org/10.1111/j.1398-9995.2012.02881.x
  138. Rajan J, Newbury RO, Anilkumar A, et al. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol. 2016;137:147-156.
  139. Kagalwalla AF, Akhtar N, Woodruff SA, et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol. 2012;129:1387-1396.
  140. Klinnert MD. Psychological impact of eosinophilic esophagitis on children and families. Immunol Allergy Clin North Am. 2009;29:99-107.
  141. Harris RF, Menard-Katcher C, Atkins D, et al. Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57:500-505.
  142. Taft TH, Kern E, Keefer L, et al. Qualitative assessment of patient-reported outcomes in adults with eosinophilic esophagitis. J Clin Gastroenterol. 2011;45:769-774.
  143. Jingsheng Z, Yuncheng L, Yingye M, et al. The mural form of eosinophilic esophagitis is accompanied by superficial esophageal squamous cell carcinoma. Case Rep Pathol. 2012;2012:315428.
  144. Fassan M, Castoro C, Saenz AJ, et al. Inflammatory myofibroblastic tumor as adverse outcome of eosinophilic esophagitis. Endoscopy. 2009;41(Suppl 2):E95-E96.
  145. Morrow JB, Vargo JJ, Goldblum JR, et al. The ringed esophagus: histological features of GERD. Am J Gastroenterol. 2001;96:984-989.
  146. Wolfsen HC, Hemminger LL, Achem SR. Eosinophilic esophagitis and Barrett’s esophagus with dysplasia. Clin Gastroenterol Hepatol. 2007;5:A18.
  147. Francalanci P, De Angelis P, Minnei F, et al. Eosinophilic esophagitis and Barrett’s esophagus: an occasional association or an overlap disease? Esophageal «double trouble» in two children. Digestion. 2008;77:16-19.
  148. Mukkada V, Atkins D, Furuta GT. Uncertain association of Barrett’s esophagus with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6:832.
  149. Ravi K, Katzka DA, Smyrk TC, et al. Prevalence of esophageal eosinophils in patients with Barrett’s esophagus. Am J Gastroenterol. 2011;106:851-857.
  150. Owens VL, Katzka DA, Lutzke LS, et al. Endoscopic ablative therapy for Barrett’s esophagus: a potential cause of eosinophilic esophagitis. Dis Esophagus. 2012;25:33-39.
  151. Lipka S, Keshishian J, Boyce HW, et al. The natural history of steroid-naive eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years. Gastrointest Endosc. 2014;80:592-598.
  152. Denning KL, Al-Subu A, Elitsur Y. Immunoreactivity of p53 and Ki-67 for dysplastic changes in children with eosinophilic esophagitis. Pediatr Dev Pathol. 2013;16:331-336.
  153. Ngo P, Furuta GT, Antonioli DA, et al. Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666-1670.
  154. Dranove JE, Horn DS, Davis MA, et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr. 2009;154:96-100.
  155. Moawad FJ, Veerappan GR, Dias JA, et al. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol. 2013;108:366-372.
  156. Peterson KA, Thomas KL, Hilden K, et al. Comparison of esoÂmeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313-1319.
  157. Molina-Infante J, Katzka DA, Gisbert JP. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis. Aliment Pharmacol Ther. 2013;37:1157-1164.
  158. Gutierrez-Junquera C, Fernandez-Fernandez S, Cilleruelo ML, et al. High revalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia. J Pediatr Gastroenterol Nutr. 2016;62:704-710.
  159. Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and metaanalysis. Clin Gastroenterol Hepatol. 2016;14:13-22. https://doi.org/10.1016/j.cgh.2015.07.041
  160. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147:1238-1254.
  161. Molina-Infante J, Rodriguez-Sanchez J, Martinek J, et al. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis. Am J Gastroenterol. 2015;110:1567-1575.
  162. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165-173.
  163. Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10:742-749. https://doi.org/10.1016/j.cgh.2012.03.018
  164. Gupta SK, Vitanza JM, Collins MH. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13:66-76.
  165. Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology. 2010;139:418-429.
  166. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo- controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381-1391.
  167. Dellon ES, Sheikh A, Speck O, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology. 2012;143:321-324.
  168. Butz BK, Wen T, Gleich GJ, et al. Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology. 2014;147:324-333.
  169. Miehlke S, Hruz P, Vieth M, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65:390-399.
  170. Tan N Di, Xiao YL, Chen MH. Steroids therapy for eosinophilic esophagitis: Systematic review and metaanalysis. J Dig Dis. 2015;16:431-442.
  171. Sawas T, Dhalla S, Sayyar M, et al. Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagiÂtis. Aliment Pharmacol Ther. 2015;41:797-806.
  172. Murali AR, Gupta A, Attar BM, et al. Topical steroids in eosinophilic esophagitis: systematic review and metaanalysis of placebo controlled randomized clinical trials. J Gastroenterol Hepatol. 2015;31:1111-1119. https://doi.org/10.1111/jgh.13281
  173. Chuang M-YA, Chinnaratha MA, Hancock DG, et al. Topical steroid therapy for the treatment of eosinophilic esophagitis (EoE): a systematic review and metaanalysis. Clin Transl Gastroenterol. 2015;6:e82. https://doi.org/10.1038/ctg.2015.9
  174. Straumann A, Conus S, Degen L, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011;9:400-409.
  175. Philla KQ, Min SB, Hefner JN, et al. Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function. J Pediatr Endocrinol Metab. 2015;28:1101-1106.
  176. Golekoh MC, Hornung LN, Mukkada VA, et al. Adrenal insufficienÂcy after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis. J Pediatr. 2016;170:240-245.
  177. Harel S, Hursh BE, Chan ES, et al. Adrenal suppression in children treated with oral viscous budesonide for eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2015;61:190-193.
  178. Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98:777-782.
  179. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1097-1102.
  180. Henderson CJ, Abonia JP, King EC, et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129:1570-1578.
  181. Peterson KA, Byrne KR, Vinson LA, et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108:759-766. https://doi.org/10.1038/ajg.2012.468
  182. Arias A, Gonzalez-Cervera J, Tenias JM, et al. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and metaanalysis. Gastroenterology. 2014;146:1639-1648.
  183. Franciosi JP, Hommel KA, DeBrosse CW, et al. Quality of life in paediatric eosinophilic oesophagitis: what is important to patients? Child Care Health Dev. 2012;38:477-483.
  184. Lucendo AJ, Sanchez-Cazalilla M, Molina-Infante J, et al. Transcultural adaptation and validation of the «Adult Eosinophilic Esophagitis Quality of Life Questionnaire» into Spanish. Rev Esp Enferm Dig. 2014;106:386-394.
  185. Spergel JM, Beausoleil JL, Mascarenhas M, et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol. 2002;109:363-368.
  186. Spergel JM, Brown-Whitehorn TF, Cianferoni A, et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol. 2012;130:461-467.
  187. Kagalwalla AF, Shah A, Ritz S, et al. Cow’s milk protein-induced eosinophilic esophagitis in a child with gluten-sensitive enteropathy. J Pediatr Gastroenterol Nutr. 2007;44:386-388.
  188. Wolf WA, Jerath MR, Sperry SLW, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1272-1279.
  189. Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, et al. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130:1200-1202.
  190. Simon D, Cianferoni A, Spergel JM, et al. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy. 2016;71:611-620.
  191. Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147:602-609.
  192. Wright BL, Kulis M, Guo R, et al. Food-specific IgG4 is associated with eosinophilic esophagitis. J Allergy Clin Immunol. 2016;138:1190-1192. https://doi.org/10.1016/j.jaci.2016.02.024
  193. Aalberse RC, Platts-Mills TA, Rispens T. The developmental history of IgE and IgG4 antibodies in relation to atopy, eosinophilic esophagitis, and the modified TH2 response. Curr Allergy Asthma Rep. 2016;16:45. https://doi.org/10.1007/s11882-016-0621-x
  194. Sicherer SH, Leung DY. Advances in allergic skin disease, anaÂphylaxis, and hypersensitivity reactions to foods, drugs and insects in 2014. J Allergy Clin Immunol. 2015;135:357-367.
  195. Kagalwalla AF, Shah A, Li BUK, et al. Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr. 2011;53:145-149.
  196. Molina-Infante J, Arias A, Barrio J, et al. Four-food group eliÂmination diet for adult eosinophilic esophagitis: a prospective multicenter study. J Allergy Clin Immunol. 2014;134:1093-1099.
  197. Philpott H, Nandurkar S, Royce SG, et al. Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities. Aliment Pharmacol Ther. 2016;44:223-233.
  198. Kagalwalla A, Amsden K, Makhija MM, et al. A multicenter study assessing the clinical, endoscopic and histologic response to four food elimination diet for the treatment of eosinophilic esophagitis. Gastroenterology. 2015;148:30.
  199. Kagalwalla AF, Amsden K, Shah A, et al. Cow’s milk elimination: a novel dietary approach to treat eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2012;55:711-716.
  200. Kruszewski PG, Russo JM, Franciosi JP, et al. Prospective, comparative effectiveness trial of cow’s milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis. Dis Esophagus. 2016;29:377-384. https://doi.org/10.1111/dote.12339
  202. Moawad FJ, Cheatham JG, DeZee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment PharÂmacol Ther. 2013;38:713-720. https://doi.org/10.1111/apt.12438
  203. Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105:1062-1070. https://doi.org/10.1038/ajg.2009.657
  204. Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc. 2010;71:706-712.
  205. Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004;59:355-361.
  206. Pasha SF, DiBaise JK, Kim HJ, et al. Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus. 2007;20:311-319.
  207. Sodikoff J, Hirano I. Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esoÂphagitis. J Allergy Clin immunol. 2016;137:631-633.
  208. Lucendo AJ, Arias A, Gonzalez-Cervera J, et al. Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2016;137:931-934. https://doi.org/10.1016/j.jaci.2015.07.033
  209. Netzer P, Gschossmann JM, Straumann A, et al. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercapÂtopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol. 2007;19:865-869.
  210. Abonia JP, Blanchard C, Butz BB, et al. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126:140-149. https://doi.org/10.1016/j.jaci.2010.04.009
  211. Arias A, Lucendo AJ, Martinez-Fernandez P, et al. Dietary treatÂment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis. Clin Exp Allergy. 2016;46:78-91.
  212. Attwood SEA, Lewis CJ, Bronder CS, et al. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut. 2003;52:181-185.
  213. Stumphy J, Al-Zubeidi D, Guerin L, Mitros F, Rahhal R. Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future. Dis Esophagus (Australia). 2011;24(4):229-234.
  214. Alexander JA, Ravi K, Enders FT, Geno DM, Kryzer LA, Mara KC, Smyrk TC, Katzka DA. Montelukast does not maintain symptom remission after topical steroid therapy for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2017;15(2):214-221.e2.
  215. Lucendo AJ, De Rezende LC, Jimenez-Contreras S, et al. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis. Dig Dis Sci. 2011;56:3551-3558.
  216. Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesoÂphagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59:21-30.
  217. Assa’ad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141:1593-1604.
  218. Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129:456-463.
  219. Rothenberg ME, Wen T, Greenberg A, et al. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;135:500-507.
  220. Rocha R, Vitor AB, Trindade E, et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr 2011;170:1471-1474.
  221. Loizou D, Enav B, Komlodi-Pasztor E, et al. A pilot study of omaÂlizumab in eosinophilic esophagitis. PLoS One. 2015;10:e0113483.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.